| Overall quality of life | ||||||
---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | |
Respondents: Stage I & II (n = 28) | 0% | 0% | 7% | 11% | 21% | 36% | 25% |
EORTC Reference Value: Stage I & II | 0% | 1% | 6% | 16% | 28% | 31% | 20% |
Respondents: Stage III & IV (n = 44) | 2% | 2% | 11% | 11% | 27% | 25% | 20% |
EORTC Reference Value: Stage III & IV | 2% | 2% | 6% | 18% | 30% | 26% | 18% |
Respondents: All patients (n = 72) | 1% | 1% | 10% | 11% | 25% | 29% | 22% |
EORTC Reference Value: All Stages | 2% | 2% | 8% | 17% | 28% | 27% | 16% |